Skip to main content

HEALTH

  • ProPhase rejects second overture from Matrixx Initiatives

    DOYLESTOWN, Pa. — ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx's latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal. 

  • GelStat updates SEC filings, positions for future growth

    PALM CITY, Fla. — GelStat is primed to grow its OTC remedy business, according to a letter to shareholders and prospective investors released Tuesday. 

  • Study: Parents confident in administering correct acetaminophen dose with AccuDial dosing label

    PALM BEACH GARDENS, Fla. — As many as 97% of parents are confident they administered the correct dose of acetaminophen when using AccuDial Pharmaceutical's weight-based dosing label, according to research published earlier this year.

  • Walgreens re-ups alliance with American Diabetes Association through 2013

    ALEXANDRIA, Va. — The American Diabetes Association on Wednesday announced that Walgreens has reaffirmed its commitment as a National Strategic Partner and will continue to help the program Stop Diabetes by supporting the association's Type 2 diabetes prevention initiative for consumers called CheckUp America. 

  • FDA cracks down on violators of dietary supplement regulations

     SILVER SPRING, Md. — The Food and Drug Administration on Thursday announced a pair of penal actions against companies operating outside of dietary supplement regulations. 

    A federal judge granted the FDA a permanent injunction against Truman Berst, doing business as Alternative Health & Herbs Remedies of Albany, Ore., for selling products represented as herbs and supplements with claims for treating diseases.

  • Novartis outsources production to bring back top-selling OTC brands to market

     BASEL, Switzerland — Progress at re-opening its manufacturing facility in Lincoln, Neb., has been slow-going, Novartis reported Thursday, but the company has contracted third-party manufacturers to resume production of Excedrin, Lamisil and Triaminic. First shipments to retailers were made in October. 

  • New York pharmacist wins Health Mart diabetes award

    NEW YORK — The owner of an independent pharmacy in New York has won a national award for his diabetes education and counseling efforts.

    Ronald Del Gaudio, a graduate of Long Island University's College of Pharmacy, also known as LIU Pharmacy, and the owner of Kings Pharmacy in the Park Slope neighborhood of Brooklyn, has won the Health Mart Diabetes Care Excellence Award from the independent pharmacy franchise company, the university said. Kings Pharmacy, a member of Health Mart, includes two pharmacies in Brooklyn and one in Manhattan.

  • Study: Aspirin may block tumor growth in certain patients with colorectal cancer

     BIRMINGHAM, Ala. — Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist. In a study that appears in the same issue, researchers examined the use of aspirin in the treatment outcomes of patients with colorectal cancer.

X
This ad will auto-close in 10 seconds